A Senescence-Centric View of Aging: Implications for Longevity and Disease

M. Borghesan , W.M.H. Hoogaars , M. Varela-Eirin , N. Talma
Trends in Cell Biology 30 ( 10) 777 -791

113
2020
T.P.1.04 Dual exon skipping in myostatin and dystrophin as a potential therapy for Duchenne muscular dystrophy

D.U. Kemaladewi , W.M.H. Hoogaars , S.H. van Heiningen , J.C.T. van Deutekom
Neuromuscular Disorders 19 ( 8) 577 -577

1
2009
O.13 Interference of myostatin and TGF-beta signaling by antisense-mediated exon skipping in ALK4/5 receptors

D.U. Kemaladewi , S.H. van Heiningen , A. Aartsma-Rus , G.J.B. van Ommen
Neuromuscular Disorders 21 ( 9) 704 -704

1
2011
O.10 Effect of combined treatment with soluble activin receptor IIB and AAV-U7-mediated dystrophin exon skipping on muscle function in mdx mice

W.M.H. Hoogaars , E. Mouisel , K. Relizani , A. Pasternack
Neuromuscular Disorders 21 ( 9) 703

2011
Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation.

Willem M. Hoogaars , Phil Barnett , Thomas Grieskamp , M. Sameer Rana
Cellular and Molecular Life Sciences 69 ( 8) 1377 -1389

90
2012
Myotube hypertrophy is associated with cancer-like metabolic reprogramming and limited by PHGDH

Lian E.M. Stadhouders , Sander A.J. Verbrugge , Jonathon A.B. Smith , Brendan M. Gabriel
bioRxiv

2020
New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration

Svitlana Pasteuning‐Vuhman , Johanna W. Boertje‐van der Meulen , Maaike Van Putten , Maurice Overzier
The FASEB Journal 31 ( 1) 238 -255

11
2017
Cell-type specific regulation of myostatin signaling

Dwi U. Kemaladewi , David J. J. Gorter , Annemieke Aartsma‐Rus , Gert‐Jan Ommen
The FASEB Journal 26 ( 4) 1462 -1472

44
2012
Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria

W. M.H. Hoogaars , A. Engel , J. F. Brons , A. O. Verkerk
Genes & Development 21 ( 9) 1098 -1112

444
2007
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy

Dwi U Kemaladewi , Willem MH Hoogaars , Sandra H van Heiningen , Samuel Terlouw
BMC Medical Genomics 4 ( 1) 36 -36

37
2011
Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGFβ Type 1 Receptor Modulation by Antisense Oligonucleotides

Sofia Karkampouna , Boudewijn PT Kruithof , Peter Kloen , Miryam C Obdeijn
Molecular therapy. Nucleic acids 3 ( 1)

18
2014
Inhibition of Activin signaling slows progression of Polycystic Kidney Disease in mice.

Wouter N Leonhard , Steven J Kunnen , Anna J Plugge , Arja Pasternack
SHEAR STRESS REGULATED SIGNALING IN RENAL EPITHELIAL CELLS AND POLYCYSTIC KIDNEY DISEASE 27 ( 12) 133 -133

2018
Reduced growth rate of aged muscle stem cells is associated with impaired mechanosensitivity

Mohammad Haroon , Heleen E Boers , Astrid D Bakker , Niek GC Bloks
Aging (Albany NY) 14 ( 1) 28 -28

11
2022
Skeletal Muscle Phenotype-Specific Effects of ACVR1B and TGFBR1 Receptor Signalling on Muscle Transcriptome, Force generation and Metabolism

Andi Shi , Michele MG Hillege , Wendy Noort , Carla Offringa
bioRxiv 2023.08. 30.555466 -2023.08. 30.555466

2023
Muscle protein synthesis, mTORC1/MAPK/Hippo

Hongqiang Ma , Philippe Pierre , Arja Pasternack , Heikki Kainulainen
Am J Physiol Endocrinol Metab 304 E41 -E50

2013
The role of IGF-1 signaling in skeletal muscle atrophy

Louk T Timmer , Willem MH Hoogaars , Richard T Jaspers
Muscle Atrophy 109 -137

92
2018
Lack of Tgfbr1 and Acvr1b synergistically stimulates myofibre hypertrophy and accelerates muscle regeneration

Michèle MG Hillege , Andi Shi , Ricardo A Galli , Gang Wu
Elife 11 e77610 -e77610

11
2022
Myotube growth is associated with cancer-like metabolic reprogramming and is limited by phosphoglycerate dehydrogenase

Lian EM Stadhouders , Jonathon AB Smith , Brendan M Gabriel , Sander AJ Verbrugge
Experimental Cell Research 433 ( 2) 113820 -113820

5
2023
The transcriptional repressor Tbx3 delineates the developing central conduction system of the heart

Willem MH Hoogaars , Alessandra Tessari , Antoon FM Moorman , Piet AJ de Boer
Cardiovascular Research 62 ( 3) 489 -499

285
2004